For Debate: Criteria for Identifying Mediators of Tissue Damage in Human Autoimmune Diseases

References

• Bendtzen K. Immune hormones (cytokines): Pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989; 2: 177–189
   PubMed Web of Science ®Google Scholar
• Ricci M, Rossi O, Romagnani S, Del Preta GF. Etiologic factors and pathogenetic aspects of organ-specific autoimmune diseases. Essential role of autoreactive T cells and lymphokine network in the activation of effector systems responsible for tissue lesions. Autoimmunity 1989; 2: 331–344
   PubMed Web of Science ®Google Scholar
• Mandrup-Poulsen T, Helqcist S, Molvig J, Wogensen L D, Nerup J. Cytokines as immune effector molecules in autoinimune endocrine diseases with specific reference to insulin-dependent diabetcs mcllitus. Autoimmunity 1989; 4: 191–218
   PubMedGoogle Scholar
• Dinarello CA. Biology of interleukin 1. FASEB 1988; 2: 108–115
   PubMed Web of Science ®Google Scholar
• Dinarello C A, Mier JW. Intcrlcukins. Ann Rev Med 1986; 37: 373–178
   Google Scholar
• Beutler B, Cerami A. Cachectin: More than a tumour necrosis factor. N Eng J Med 1986; 316: 379–385
   Google Scholar
• Le J, Vilcek J. Biology of Disease. Tumour necrosis factor and interleukin I: Cytokins with multiple overlapping biological activities. Laboratory Invest 1987; 56: 234–248
   PubMed Web of Science ®Google Scholar
• Dingle JT. Saklatvala J, Hembury R, Tyler J, Fell H, Jubb R. A cartilage catabolic factor from synovium. Biochem J 1979; 184: 177–180
   PubMed Web of Science ®Google Scholar
• Saklatvala J, Dingle J. Identification of catabolin. a protein from synovium which induces degradation of cartilage in organ culture. Biochem Biophys Res C'omm 1980; 96: 1225–1231
   PubMed Web of Science ®Google Scholar
• Saklatvala J, Sarsfield SJ. Townscnd Y. Pig interleukin. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation and fever. J Exp Med 1985; 162: 1208–1222
   PubMed Web of Science ®Google Scholar
• Saklatvala J. Tumour necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322: 547–549
   PubMed Web of Science ®Google Scholar
• Steinberg JJ. Hubbard JR. Sledge CB. Chondrocyte-mediated breakdown of cartilage. J Rheumatol 1987; 14: 55–58
   PubMed Web of Science ®Google Scholar
• Dingle JT. The role of cellular interactions in joint erosions. Clin Orthop Rel Res 1984; 182: 24–30
   PubMedGoogle Scholar
• Wood D D, Ihrie E J, Hamerman D. Release of interleukin-l from human synovial tissue in vitro. Arthritis Rheum 1985; 28: 853–862
   PubMed Web of Science ®Google Scholar
• Buchan G, Barrett K, Turner M, Chantry D, Maini R N, Feldmann M. Interleukin-l and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-lα. Clin ESP Immunol 1988; 73: 449–455
   PubMed Web of Science ®Google Scholar
• Yocum D E, Esparza S, Dubry S, Benjamin J B, Volz R, Scuderi P. Characteristics of tumour necrosis factor production in rheumatoid arthritis. Cell Immunol 1989; 122: 131–145
   PubMed Web of Science ®Google Scholar
• Fontana A, Hengartner H, Weber E, Fehr K, Grob P J, Cohen G. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982; 2: 49–53
   PubMed Web of Science ®Google Scholar
• Wood D D, Thrie E J, Dinarello C A, Cohen PL. Isolation of an intcrleukin-l-like factor from human joint effusions. Arthritis Rheum 1983; 26: 975–983
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Peterson J, Halkjaer-Kristensen J, Ingemann-Hansen T. Interleukin-I-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis. Rheumatol Int 1985; 5: 79–82
   PubMed Web of Science ®Google Scholar
• DiGiovine F S, Manson J, Nuki G, Duff GW. Tumour necrosis factor activity in synovial exudate fluids from patients with OA and RA. Br J Rheumatol 1986; 25: 108
   Google Scholar
• Miossec P, Dinarello C A, Ziff M. Interleukin-l Iymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986; 29: 461–470
   PubMed Web of Science ®Google Scholar
• Hopkins S J, Meager A. Cytokines in synovial fluid. II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988; 73: 88–92
   PubMed Web of Science ®Google Scholar
• Hopkins SJ. Huniphreys M, Jayson MIV. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-l. Clin Exp Immunol 1988; 72: 422–427
   PubMedGoogle Scholar
• Symons J A, McDowell T L, DiGiovine F S, Wood N S, Capper SJ. Duff GW. Interleukin 1 in rheumatoid arthritis: Potentiation of immune responses within the joint. Lymphokine Res 1989; 8: 365–372
   PubMedGoogle Scholar
• Clay K, Seed MP. Clemen-Jewery S. Studies on interleukin-1β induced glycosaininoglycans release from rat femoral head cartilage. in vitro. J Pharm Pharmacol 1989; 41: 504–504
   Google Scholar
• Pettipher E R, Higgs G A, Henderson B. interleukin-I induces leukocyte infiltration and proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986; 83: 8749–8753
   PubMed Web of Science ®Google Scholar
• Dingle J T, Page-Thomas D P, King B, Bard DR. In vivo studies of articular tissue damage mediated by catabolin/interleukin I. Ann Rheum Dis 1987; 46: 527–533
   PubMed Web of Science ®Google Scholar
• Henderson B, Pettipher ER. Comparison of the in vivo inflammatory activities after intra-articular injection of natural and recombinant IL-lα and IL-lβ in the rabbit. Biochem Pharmacol 1988; 37: 4171–4176
   PubMedGoogle Scholar
• Henderson B, Pettipher ER. Arthritogenic action of recombinant IL-1 and tumour necrosis factor a: in the rabbit: evidence for synergistic action between cytokines. in vivo. Clin Exp Immunol 1989; 75: 306–310
   PubMed Web of Science ®Google Scholar
• Van de Loo A AJ, Van den Berg WB. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurements of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990; 49: 238–245
   PubMed Web of Science ®Google Scholar
• Todd I, Bottazzo GF. In reply to Dr Mandrup-Poulsen. et al. Autoimmunity 1989; 4: 219–223
   Google Scholar
• Rabinovitch A. In reply to Dr Mandrup-Poulsen. et al. Autoimmunity 1989; 4: 224–227
   Google Scholar
• Campbell IL. In reply to Dr Mandrup-Poulsen. et al. Autoimmunity 1989; 4: 227–230
   Google Scholar
• Mandrup-Poulsen T, Helmqvist S, Molvig J, Wogensen L D, Nerup J. Responses to critiques from Drs. Todd and Botazzo, Rabinovitch and Campbell. Autoimmunity 1989; 4: 230–234
   Google Scholar
• Paton W DM. Central and synaptic transmission in the nervous system (pharmacological aspects). Ann Rev Physiol 1958; 20: 431–470
   PubMedGoogle Scholar
• Orrego F. Criteria for the identification of neurotransmitters, and their application to studies with some nerve tissue preparations. in vitro. Neuroscience 1979; 4: 1037–1057
   PubMedGoogle Scholar
• Dale HH. Progress in autopharmacology; survey of present knowledge of chemical regulation of certain functions by natural constituents of tissues. Bull Johns Hopkins Hospital 1933; 53: 297–312
   Google Scholar
• Dale HH. Chemical transmission of effects of nerve impulses. Br Med J 1934; i: 835–841
   Google Scholar
• Werman R. Criteria for identification of a central nervous system transmitter. Comp Biochem Physiol 1966; 18: 745–766
   PubMedGoogle Scholar
• Weiner N, Taylor P. Neurohumoral transmission: The autonomic and somatic motor nervous systems. Goodman and Gilman's the pharmacological basis of therapeutics, 7th edition, A Good-man-Gilman, LS Goodman, TW Rall, F Murad. Macmillan, New York 1985; 66–99
   Google Scholar
• Benzouyad A, Hollander A P, Dularay B, Bedwell A E, Cooper R A, Hutton C W, Dieppe P A, Elson CJ. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis. Ann Rheum Dis 1990; 49: 301–307
   PubMedGoogle Scholar
• Hollander AP. Inflammation and joint damage in rheumatoid arthritis. University of Bristol. 1990, PhD thesis
   Google Scholar
• Westacott C I, Witcher J T, Barnes I C, Thompson D, Swan A J, Dieppe PA. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990, in press
   PubMedGoogle Scholar
• Hollander A P, Atkins R M, Eastwood D M, Dieppe P A, Elson CJ. Quman cartilage is degraded by rheumatoid arthritis synovial fluid but not recombinant cytokines. in vitro. Clin Exp Immunol 1990, in press
   Google Scholar
• Hannum C H, Wilcox C J, Arend W P, Josh F G, Dripps D J, Heimdal P L, Armes L G, Sommer A A, Eisenberg S P, Thompson RC. Interleukin-l receptor antagonist activity of a human interleukin-l inhibitor. Nature 1990; 343: 336–340
   PubMed Web of Science ®Google Scholar
• Eisenberg S P, Evans R J, Arend W P, Verdeber E, Brewer M T, Hannum C H, Thompson RC. Primary structure and functional expression of a human interleukin-I receptor antagonist. Nature 1990; 343: 341–346
   PubMed Web of Science ®Google Scholar
• Carter D B, Deibel M R, Dunn C J, Tomich C-SC, Laborde A L, Slightom J L. Purification, cloning expression and biological characterization of an interleukin I receptor antagonist protein. Nature 1990; 344: 633–638
   PubMed Web of Science ®Google Scholar